BioSpace News Archive

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”) has today announced it has been granted a licence by UniQuest, the commercialisation company of The University of Queensland (UQ), to novel zinc ionophore technology to combat antimic

CureDuchenne, a leading global nonprofit focused on funding and finding a cure for Duchenne muscular dystrophy, announced today a new initiative to deliver free medical ID bracelets to individuals in the United States living with Duchenne. With an initial limited quantity of 1,200 bracelets supplied by MyID, a leading provider of medical bracelets, they will be distributed on a first-come-first-serve basis. Ea

Atomwise, the leader in using artificial intelligence for small-molecule drug discovery, unveiled its growing portfolio of emerging joint venture companies with research programs spanning oncology, immunology, infectious disease, neuroscience and clotting disorders.

Gut Feelings: Disorders of Gut-Brain Interaction (DGBI) and the Patient-Doctor Relationship, a culmination of decades of learnings in the gastroenterology space, now available

Surgical imaging is one of the revolutionary technology for optical imaging that is utilized for image guide surgical process.

Lidocaine is a local anesthetic medication that is used to numb an area in the body in order to reduce pain or discomfort caused by invasive medical procedures such as surgery, needle punctures, or insertion of a catheter or breathing tube.

Dandy-Walker Syndrome is a congenital brain malformation of the fluid-filled spaces around the cerebellum

Patient recruitment in Phase III trial has surpassed 60% Trial is expanded to Israel with first clinical site at Tel Aviv Medical Center

Evofem Biosciences, Inc., (NASDAQ: EVFM) today announced it will present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference.

Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of a rapid and painless testing platform based on its patented biophotonic technology, announced the opening of a new LuViva Reference and Training Center (“Center of Excellence”) in Budapest, Hungary to support sales and training in Europe. The